Literature DB >> 30376812

Giant cell arteritis presenting as bilateral anterior ischemic optic neuropathy: a biopsy-proven case report in Chinese patient.

Guohong Tian1,2, Weimin Chen3, Qian Chen4, Min Wang4,5, Guixian Zhao6, Zhenxin Li6, Jiong Zhang7.   

Abstract

BACKGROUND: Giant cell arteritis (GCA) is a systemic vasculitis of medium and large-size vessels and can led to permanent visual loss in elderly patients. GCA is very rare among Asians. We report a Chinese patient presenting with acute bilateral anterior ischemic optic neuropathy, and the temporal artery biopsy proved the diagnose of GCA. CASE
PRESENTATION: A 77-year-old Chinese man presented with sudden bilateral blindness for 5 days with a severe headache. Funduscopic examination revealed bilateral optic disc swollen with "chalky white" pallid appearance. The blood tests showed the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) elevated dramatically. The color duplex ultrasonography (CDUS) of the superficial temporal artery revealed the inflammation of the vessel wall as a "halo sign". The temporal artery biopsy was perfumed and the pathology revealed luminal occlusion with multinuclear giant cell infiltration. The patient was treated with intravenous methylprednisolone for 3 days and oral prednisone weaning for 12 months. The visual acuity remained no light perception at one year follow-up.
CONCLUSIONS: Although very rare in Asian, GCA can led to permanent blindness in elderly Chinese caused by anterior ischemic optic neuropathy. The noninvasive CDUS might be a promising technique for diagnose GCA in highly suspected patients.

Entities:  

Keywords:  Anterior ischemic optic neuropathy; Asian; Giant cell arteritis; Temporal biopsy; Ultrasonography

Mesh:

Substances:

Year:  2018        PMID: 30376812      PMCID: PMC6208180          DOI: 10.1186/s12886-018-0953-5

Source DB:  PubMed          Journal:  BMC Ophthalmol        ISSN: 1471-2415            Impact factor:   2.209


Background

Giant cell arteritis as a common systemic vasculitis in Western adults, was seen 20 times less frequently in Asian than in Caucasian patients [1-3]. The epidemiological studies have rarely been addressed and according to Kobayashi et al., the prevalence in Japan is 1.47 per 100 000 [4]. Two large sample studies in China mainland showed the clinical manifestations of GCA in Chinese patients were similar to those previously described in literature [5, 6]. Arteritic anterior ischemic optic neuropathy (A-AION) due to GCA, which accounting for 85% of cases of permanent vision loss [7], had not been reported in China so far, except for several presumed cases without biopsy published in non-English literature. We reported an Asian elderly patient with sudden bilateral blindness as initial symptom presented to ophthalmologist, and the afterwards biopsy convinced the pathogenesis of GCA.

Case presentation

A 77-year-old Chinese man complained of bilateral, simultaneous onset vision loss for 5 days, accompanied by severe headache on right side and jaw pain. He was a considerable healthy man in the past. The Neuro-Ophthalmological examination revealed the patient to be alert and oriented. The visual acuities were no light perception in both eyes. The pupils were dilated with no reaction to light. Slit lamp examination showed punctate cataract and funduscopic examination revealed diffused swollen of the optic disc bilateral, with pallid “chalky white” appearance; the choroids showing diffused atrophy around the optic disc bilateral (Fig. 1). The extra-ocular motility was full of both eyes. The bilateral superficial temporal arteries were palpable and tenderness.
Fig. 1

Fundus photographs at presentation of the patient showing severe bilateral optic disc swollen, with “chalky white” pallid appearance; there are splinter hemorrhage and cotton wool spots on the retina in the right eye. The choroid showing diffused atrophy around the optic disc

Fundus photographs at presentation of the patient showing severe bilateral optic disc swollen, with “chalky white” pallid appearance; there are splinter hemorrhage and cotton wool spots on the retina in the right eye. The choroid showing diffused atrophy around the optic disc The routine laboratory tests showed slight decreased RBC (3.09 × 1012/L, normal: 4–5.5) and Hb (92 g/l, normal:120–160),with normal platelet count (170 × 109/L, normal:100–300);dramatic elevated erythrocyte sedimentation ratio (ESR: 100 mm/h, normal: 0–15) and C-reactive protein (CRP: 39.27 mg/L, normal: 0–5). The ocular blood flow detected by color duplex ultrasonography (CDUS) revealed decrease of posterior ciliary artery, central retinal artery, ophthalmic artery in both eyes. CDUS of the bilateral superficial temporal arteries with high-frequency linear probe revealed inflammation of the vessel wall as a hypo-echoic concentric ring, which referred as the “halo sign” [8] (Fig. 2). The orbital fat-suppression T1-weighted magnetic resonance imaging (MRI) with contract only showed the enhancement of the optic nerve sheath in the left eye, without inflammatory and mass occupation lesions. The MRA were also unremarkable (Fig. 3). The right temporal artery biopsy was performed and revealed the occlusion of the luminal owing to the intimal proliferation and infiltration (Fig. 4). Methylprednisolone 1 g/d was intravenous for 3 days followed by prednisone 1 mg/kg/d. The vision acuity maintained NLP bilateral after treatment, whereas the headache and jaw pain disappeared. The oral prednisone was weaned and methotrexate was added as the immunosuppressive agent for long treatment. The patient was followed more than one year and there was no other new systematic symptoms, but with the permanent blindness eventually.
Fig. 2

The color duplex ultrasonography showing the right superficial temporal artery of the patient: (a): the accelerating of the blood flow indicate the narrowing of the vessel; (b): the inflammation of the vessel wall as a hypo-echoic concentric ring, which referred as the “halo sign”. The blue arrow indicates the thickening vessel wall; the red arrow indicates the narrowed luminal

Fig. 3

The orbital fat-suppression T1-weighted magnetic resonance imaging with contract showing the enhancement of the optic nerve sheath in the right eye, (a):axial and (b): sagittal. The white arrows indicate the optic nerve sheath; the MRA of the cerebral vascular is unremarkable (c)

Fig. 4

Histopathology of right temporal arterial biopsy showing the almost occlusion of the luminal (asterisk), and diffused infiltration of inflammation by lymphocytes, macrophages and multinuclear giant cells in the arterial wall (white arrows). (a): H&E × 40. (b): H&E × 100

The color duplex ultrasonography showing the right superficial temporal artery of the patient: (a): the accelerating of the blood flow indicate the narrowing of the vessel; (b): the inflammation of the vessel wall as a hypo-echoic concentric ring, which referred as the “halo sign”. The blue arrow indicates the thickening vessel wall; the red arrow indicates the narrowed luminal The orbital fat-suppression T1-weighted magnetic resonance imaging with contract showing the enhancement of the optic nerve sheath in the right eye, (a):axial and (b): sagittal. The white arrows indicate the optic nerve sheath; the MRA of the cerebral vascular is unremarkable (c) Histopathology of right temporal arterial biopsy showing the almost occlusion of the luminal (asterisk), and diffused infiltration of inflammation by lymphocytes, macrophages and multinuclear giant cells in the arterial wall (white arrows). (a): H&E × 40. (b): H&E × 100

Discussion and conclusion

GCA represents a rare systematic granulomatous vasculitis in Asian, with fever and headache as the most prominent symptoms at onset [5, 6]. An arteritic anterior ischemic optic neuropathy (A-AION) from inflammatory occlusion of posterior ciliary artery is the most common cause of permanent visual loss. Attaseth et al. [9] had reported six A-AION patients in Thailand with biopsy-proven GCA and Cha et al. reported one case from Koreans [10]. To our knowledge, this is the first report of A-AION due to GCA confirmed with biopsy in Chinese patient. The clinical features and visual outcome of our Chinese patient is not different from those described in Caucasian or Asians from Thailand and Korea [11]. The rapid progressed visual loss in elderly with headache, the “chalky white” pallid disc, as well as the evaluated ESR and CRP, the presumed GCA is not very difficult for ophthalmologists to made, even though patients without the systemic manifestation of GCA. According to the criteria for diagnose of GCA in 1990, the biopsy is not the necessary condition, but it’s still the gold standard for GCA [12]. Because of the extremely low prevalence of GCA in Asian, the other types of vasculitis such as Wegener granulomatosis, nodular polyarteritis, or Behcet disease should be as the differentiations, and polymyalgia rheumatic as an overlap with GCA. Murchison et al. suggested that all patients suspected of having GCA should undergo a temporal artery biopsy [13]. Some authors commented on the “rare” of GCA in Asian populations is likely to be under-recognized and misdiagnoses, owing to the low biopsy rate [14]. Therefor the CDUS as an noninvasive vascular imaging has an important role in the diagnostic and work-up of large-vessel vasculitis, especially in GCA patients. We also utilized the ultrasound for evaluating the superficial temporal arteries before the biopsy was performed. Using the high-frequency linear probe, the inflammation of the vessel wall can be detected as a hypo-echo concentric ring, which referred as “halo sign”. More clinical evaluation and compared study will be help to obtain a normal temporal arteries normal value in Asian patients. Although the MRI of the optic nerve would not help to differentiate the arteritic AION from the N-AION, the perio-optic nerve sheath enhancement was also observed in our patient, just as reported in Asian patients before [9]. The unremarkable diffused weighted imaging of the optic nerve of the orbit part can help ophthalmologists to exclude the posterior optic neuropathies due to other inflammatory or infiltration [15]. Because GCA is a rapid progressive irreversible blindness condition, although very rare in Asian patients, the vigilant for quick ESR and CRP tests is very important. The high dose of corticosteroid treatment should not be delayed while waiting for the result of biopsy. In conclusion, although A-AION due to GCA is very rare in Asian patients, the sudden devastating visual loss with headache in elderly, the white chalk pallid disc, and the evaluated ESR and CRP will differentiate it from the common N-AION type. We emphasize that noninvasive ultrasound and MRI will be a very promising methods for work-up GCA in Asian in case the biopsy is impossible.
  15 in total

1.  [Clinical features and treatment of giant cell arteritis in Chinese, a prospective study].

Authors:  Zhiping Hu; Qidong Yang; Jinghe Li; Shan Zeng; Xiaoying Wu; Li Cao; Li Yang; Xingwang Song
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2002-04-10

2.  Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey.

Authors:  Shigeto Kobayashi; Tetsuro Yano; Yoshifuji Matsumoto; Fujio Numano; Nobuyuki Nakajima; Keishu Yasuda; Chikao Yutani; Toshiko Nakayama; Akiko Tamakoshi; Takashi Kawamura; Yoshiyuki Ohno; Yutaka Inaba; Hiroshi Hashimoto
Journal:  Arthritis Rheum       Date:  2003-08-15

3.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.

Authors:  G G Hunder; D A Bloch; B A Michel; M B Stevens; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

4.  Assessment of nonarteritic anterior ischemic optic neuropathy with intravoxel incoherent motion diffusion-weighted imaging using readout-segmented echo-planar imaging, parallel imaging, and 2D navigator-based reacquisition.

Authors:  Ping Lu; Yan Sha; Hailin Wan; Feng Wang; Guohong Tian; Wenlin Tang
Journal:  J Magn Reson Imaging       Date:  2017-05-17       Impact factor: 4.813

5.  Validity of the American College of Rheumatology criteria for the diagnosis of giant cell arteritis.

Authors:  Ann P Murchison; Molly E Gilbert; Jurij R Bilyk; Ralph C Eagle; Victoria Pueyo; Robert C Sergott; Peter J Savino
Journal:  Am J Ophthalmol       Date:  2012-07-17       Impact factor: 5.258

Review 6.  Diagnosis and management of giant cell arteritis: a review.

Authors:  Nilufer Kale; Eric Eggenberger
Journal:  Curr Opin Ophthalmol       Date:  2010-11       Impact factor: 3.761

7.  Giant cell arteritis in Asians: a comparative study.

Authors:  Luciano S Pereira; Michael K Yoon; Thomas N Hwang; Jenny E Hong; Kathyrn Ray; Travis Porco; Timothy J McCulley
Journal:  Br J Ophthalmol       Date:  2010-06-28       Impact factor: 4.638

8.  Evaluating the Incidence of Arteritic Ischemic Optic Neuropathy and Other Causes of Vision Loss from Giant Cell Arteritis.

Authors:  John J Chen; Jacqueline A Leavitt; Chengbo Fang; Cynthia S Crowson; Eric L Matteson; Kenneth J Warrington
Journal:  Ophthalmology       Date:  2016-06-11       Impact factor: 12.079

9.  Silent giant cell arteritis in an elderly Korean woman.

Authors:  Dong Min Cha; Taeseung Lee; Gheeyoung Choe; Hee Kyung Yang; Jeong-Min Hwang
Journal:  Korean J Ophthalmol       Date:  2013-04-25

10.  A Retrospective Study of Chinese Patients With Giant Cell Arteritis (GCA): Clinical Features and Factors Associated With Severe Ischemic Manifestations.

Authors:  Fei Sun; Sha Ma; Wenjie Zheng; Xinping Tian; Xiaofeng Zeng
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

View more
  2 in total

Review 1.  Giant cell arteritis: Its ophthalmic manifestations.

Authors:  Sohan Singh Hayreh
Journal:  Indian J Ophthalmol       Date:  2021-02       Impact factor: 1.848

2.  Giant Cell Arteritis Presenting With Ocular Symptoms: Clinical Characteristics and Multimodal Imaging in a Chinese Case Series.

Authors:  Qian Chen; Weimin Chen; Chaoyi Feng; Deshan Gong; Jiong Zhang; Yingwen Bi; Ping Sun; Xinghuai Sun; Guohong Tian
Journal:  Front Med (Lausanne)       Date:  2022-06-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.